Privi Speci.

Who are in the management team of Privi Speci.?

As of March 2023, the management team of Privi Speci includes Mahesh Babani (Chairman & Managing Director), D B Rao (Executive Director), and several Non-Executive & Independent Directors, along with a Company Secretary and an Additional Director. This team oversees the company's governance and operations.

As of March 2023, the management team of Privi Speci includes the following individuals:<BR><BR>1. Mahesh Babani - Chairman & Managing Director<BR>2. D B Rao - Executive Director<BR>3. Rajesh Budhrani - Non-Executive & Independent Director<BR>4. P R Barpande - Non-Executive & Independent Director<BR>5. Anurag Surana - Non-Executive & Independent Director<BR>6. D T Khilnani - Non-Executive & Independent Director<BR>7. Anuradha Eknath Thakur - Independent Director<BR>8. Ashwini Saumil Shah - Company Secretary & Compliance Officer<BR>9. Hemang Manhar Gandhi - Additional Director<BR><BR>These members play various roles within the company, contributing to its governance and operational management.

What is the bonus history of the Privi Speci.?

Privi Speciality Chemicals Ltd has issued bonuses in the following ratios: 1:10 on July 9, 2014 (record date July 10, 2014), 1:10 on July 3, 2013 (record date July 4, 2013), and 1:5 on July 12, 2012 (record date July 16, 2012).

Privi Speciality Chemicals Ltd has a history of bonus issues as follows:<BR><BR>1. On July 9, 2014, the company announced a bonus issue in the ratio of 1:10, with the record date being July 10, 2014.<BR>2. Prior to that, on July 3, 2013, there was another bonus issue also in the ratio of 1:10, with the record date on July 4, 2013.<BR>3. Additionally, on July 12, 2012, the company issued a bonus in the ratio of 1:5, with the record date being July 16, 2012.<BR><BR>This reflects the company's approach to rewarding its shareholders through bonus shares over the years.

Has Privi Speci. declared dividend?

Privi Speciality Chemicals Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of July 24, 2024. The company has shown strong price returns over various periods, despite a low dividend yield of 0.07%.

Privi Speciality Chemicals Ltd has declared a 20% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2<BR>- Ex-date: 24 Jul 24<BR><BR>Dividend Yield: 0.07%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 22.38%, with a dividend return of 0%, resulting in a total return of 22.38%.<BR><BR>Over the past year, the price return was 92.08%, the dividend return was 0.17%, leading to a total return of 92.25%.<BR><BR>In the 2-year period, the price return stood at 97.83%, while the dividend return was 0.18%, culminating in a total return of 98.01%.<BR><BR>For the 3-year period, the price return was 98.84%, with a dividend return of 0.38%, resulting in a total return of 99.22%.<BR><BR>In the last 4 years, the price return was 120.34%, the dividend return was 0.55%, which brought the total return to 120.89%.<BR><BR>Finally, over the 5-year period, the price return reached 371.26%, with a dividend return of 1.28%, leading to a total return of 372.54%.<BR><BR>Overall, Privi Speciality Chemicals Ltd has declared a dividend, albeit with a relatively low dividend yield, while demonstrating strong price returns across all periods, indicating robust growth in its stock value.

Who are the peers of the Privi Speci.?

Peers of Privi Speci. include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Galaxy Surfact., Elantas Beck, Epigral, Archean Chemical, and Laxmi Organic. Privi Speci. has a 1-year return of 99.98%, outperforming its peers, with Himadri Special showing the highest return at 40.70%.

Peers: The peers of Privi Speci. are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Galaxy Surfact., Elantas Beck, Epigral, Archean Chemical, and Laxmi Organic.<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, Galaxy Surfact., Elantas Beck, Epigral, and Archean Chemical, while Good management risk is found at Pidilite Inds., SRF, and the rest. Average management risk is noted at Gujarat Fluoroch, Himadri Special, Privi Speci., and Laxmi Organic. Growth is Average at Pidilite Inds. and SRF, while Below Average growth is seen at Gujarat Fluoroch, Deepak Nitrite, Galaxy Surfact., Elantas Beck, Epigral, Archean Chemical, and the rest. Good growth is observed at Himadri Special, while Privi Speci. and Laxmi Organic show Below Average growth. Capital Structure is Excellent at Pidilite Inds., SRF, Deepak Nitrite, Galaxy Surfact., Elantas Beck, Archean Chemical, and the rest, while Good capital structure is found at Gujarat Fluoroch and Himadri Special, and Below Average at Privi Speci.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Himadri Special at 40.70%, while the lowest is Deepak Nitrite at -9.57%. Privi Speci. has a 1-year return of 99.98%, which is significantly higher than all peers. Additionally, the peers with negative six-month returns include Deepak Nitrite, Galaxy Surfact., Elantas Beck, and Laxmi Organic.

What does Privi Speci. do?

Privi Speciality Chemicals Ltd is a mid-cap manufacturer and exporter of aroma and fragrance chemicals, with recent net sales of ₹6,136 Cr and a net profit of ₹665 Cr as of March 2025. The company has a market cap of ₹9,470 Cr and key financial metrics include a P/E ratio of 50.00 and a return on equity of 16.95%.

Overview: <BR>Privi Speciality Chemicals Ltd is a leading manufacturer, supplier, and exporter of aroma and fragrance chemicals in the specialty chemicals industry, categorized as a mid-cap company.<BR><BR>History: <BR>The company was incorporated in an unspecified year and has maintained its status as a prominent player in the aroma chemicals sector. The latest quarterly results reported are for March 2025, showcasing significant sales and profit figures.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 6,136 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 665 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 9,470 Cr (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 50.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.08% <BR>Debt-Equity: 0.98 <BR>Return on Equity: 16.95% <BR>Price-to-Book: 8.62 <BR><BR>Contact Details: <BR>Address: Plot No A-71 TTC, Thane-Belapur Road Navi Mumbai Maharashtra : 400709 <BR>Tel: 91-022-27783040/27783041 <BR>Email: cs@adifinechem.com/sales@privi.co.i <BR>Website: http://www.fairchem.in

Who are the top shareholders of the Privi Speci.?

The top shareholders of Privi Speci. include Vivira Investment And Trading Private Limited with 39.67%, followed by Banbridge Limited at 6.1%, and individual investors holding 14.16%. Additionally, mutual funds own 1.42%, and foreign institutional investors hold 0.4%, with no pledged promoter holdings reported.

The top shareholders of Privi Speci. include several key players. The majority shareholders are the promoters, with Vivira Investment And Trading Private Limited holding the largest stake at 39.67%. In terms of public shareholders, Banbridge Limited is the highest, owning 6.1%. Additionally, individual investors collectively hold 14.16% of the company. Mutual funds have a presence with 1.42% held by one scheme, while foreign institutional investors (FIIs) hold 0.4% across 37 different entities. Notably, there are no pledged promoter holdings reported.

How big is Privi Speci.?

As of 24th July, Privi Speciality Chemicals Ltd has a market capitalization of 9,582.00 Cr, with recent net sales of 2,101.19 Cr and a net profit of 186.99 Cr. Shareholder's funds are 1,103.43 Cr, and total assets are 2,790.51 Cr.

As of 24th July, Privi Speciality Chemicals Ltd has a market capitalization of 9,582.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 2,101.19 Cr and a Net Profit of 186.99 Cr.<BR><BR>For the latest annual period ending March 2025, Shareholder's Funds amounted to 1,103.43 Cr, while Total Assets were reported at 2,790.51 Cr.

Is Privi Speci. overvalued or undervalued?

As of September 5, 2025, Privi Speci. is considered very expensive and overvalued with a PE Ratio of 40.97 and an EV to EBITDA of 20.50, despite outperforming the Sensex with a 1-year return of 53.31%.

As of 5 September 2025, the valuation grade for Privi Speci. has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is currently considered overvalued. Key ratios include a PE Ratio of 40.97, an EV to EBITDA of 20.50, and a Price to Book Value of 8.08, all of which suggest that the stock is trading at a premium compared to its earnings and assets.<BR><BR>In comparison to its peers, Privi Speci. has a higher PE Ratio than Godrej Industries, which stands at 40.09, and significantly lower than Solar Industries, which is at 99.93. The PEG Ratio of 0.52 indicates potential growth relative to its price, but the overall valuation metrics suggest that the stock is not justified at its current price level. Notably, Privi Speci. has outperformed the Sensex with a 1-year return of 53.31% compared to the Sensex's decline of 1.81%, yet this strong performance does not mitigate the concerns regarding its high valuation.

Is Privi Speci. technically bullish or bearish?

As of October 7, 2025, the trend has shifted to bullish with moderate strength, supported by positive monthly MACD and moving averages, although caution is advised due to mildly bearish weekly indicators.

As of 7 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators driving this include the monthly MACD being bullish, daily moving averages indicating bullish momentum, and both weekly and monthly Bollinger Bands showing bullish signals. However, the weekly MACD and KST are mildly bearish, suggesting some caution. Overall, the strong performance relative to the Sensex, particularly in the 1Y and 5Y periods, supports the bullish outlook.

How has been the historical performance of Privi Speci.?

Privi Speci. has shown significant growth in net sales and profits, with net sales increasing from 1,276.56 Cr in March 2021 to 2,101.19 Cr in March 2025, and profit after tax rising from 21.28 Cr to 184.75 Cr during the same period, indicating strong financial performance and operational efficiency.

Answer:<BR>The historical performance of Privi Speci. shows a significant upward trend in net sales and profits over the years, culminating in the fiscal year ending March 2025.<BR><BR>Breakdown:<BR>Privi Speci. has demonstrated robust growth in net sales, increasing from 1,276.56 Cr in March 2021 to 2,101.19 Cr in March 2025. This growth is reflected in the total operating income, which rose from 1,324.11 Cr in March 2020 to 2,101.19 Cr in March 2025. The company's operating profit (PBDIT) also showed a positive trend, climbing from 243.51 Cr in March 2020 to 474.16 Cr in March 2025, indicating improved operational efficiency. Profit before tax surged from 31.04 Cr in March 2023 to 254.52 Cr in March 2025, while profit after tax increased from 21.28 Cr to 184.75 Cr in the same period. The earnings per share (EPS) saw a remarkable rise from 5.69 in March 2023 to 47.88 in March 2025. On the balance sheet, total assets grew from 1,383.69 Cr in March 2020 to 2,790.51 Cr in March 2025, with total liabilities also increasing from 1,128.37 Cr to 2,790.51 Cr. The company maintained a stable equity capital of 39.06 Cr throughout the years. Cash flow from operating activities improved significantly, reaching 281.00 Cr in March 2025, despite cash flow from investing activities remaining negative. Overall, Privi Speci. has shown a strong financial performance with increasing revenues, profits, and asset growth over the years.

When is the next results date for Privi Speciality Chemicals Ltd?

The next results date for Privi Speciality Chemicals Ltd is 09 February 2026.

The next results date for Privi Speciality Chemicals Ltd is scheduled for 09 February 2026.

Are Privi Speciality Chemicals Ltd latest results good or bad?

Privi Speciality Chemicals Ltd's latest results show strong year-on-year growth, with a 75.50% increase in net profit and a 23.18% rise in net sales. However, there are concerns due to quarter-on-quarter declines in both net profit and sales, indicating potential volatility in maintaining growth.

Privi Speciality Chemicals Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹77.99 crores for Q3 FY26, which is a significant increase of 75.50% year-on-year. Additionally, net sales reached ₹604.64 crores, reflecting a healthy year-on-year growth of 23.18%. The operating margin also improved to 25.03%, indicating enhanced operational efficiency.<BR><BR>However, when looking at the quarter-on-quarter performance, there are notable declines. Both net sales and net profit decreased by 10.91% and 16.95%, respectively, compared to the previous quarter. This sequential decline raises concerns about the sustainability of the growth seen in previous quarters.<BR><BR>Overall, while the year-on-year figures are impressive and suggest strong operational performance, the sequential declines indicate potential volatility and challenges in maintaining growth momentum. Investors may want to consider these mixed signals when evaluating the company's performance.

Should I buy, sell or hold Privi Speciality Chemicals Ltd?

Which are the latest news on Privi Speci.?

Why is Privi Speciality Chemicals Ltd falling/rising?

As of 09-Mar, Privi Speciality Chemicals Ltd's stock price has risen to Rs 2,924.05, driven by strong long-term growth and consistent positive financial results, including a 30.71% increase in annual operating profit and a 23.83% growth in net sales. The company has outperformed benchmark indices, achieving a 92.07% return over the past year, despite a recent decline in investor participation.

As of 09-Mar, Privi Speciality Chemicals Ltd is experiencing a rise in its stock price, currently at Rs 2,924.05, reflecting an increase of 28.95 (1.0%). This upward movement can be attributed to several factors highlighted in the recent performance data. <BR><BR>The stock has shown strong long-term growth, with an annual operating profit increase of 30.71%. Additionally, the company has reported positive results for the last ten consecutive quarters, with net sales for the first nine months reaching Rs 1,842.16 crore, marking a growth of 23.83%. The return on capital employed (ROCE) is at a robust 19.32%, and the debt-equity ratio is notably low at 0.86 times, indicating a healthy financial position.<BR><BR>Moreover, the stock has outperformed the benchmark indices over various time frames, achieving a remarkable 92.07% return over the past year, while also surpassing the BSE500 in the last three years, one year, and three months. Despite a slight decline in investor participation, with delivery volume dropping by 42.92% against the five-day average, the stock's overall performance remains strong, particularly in the long term. <BR><BR>In summary, the combination of consistent positive financial results, strong growth metrics, and market-beating performance contributes to the rising stock price of Privi Speciality Chemicals Ltd.